AI-Assisted endoscopy aims to reduce missed stomach lesions

NCT ID NCT06495645

Recruiting now Diagnosis Sponsor: The University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares AI-assisted upper endoscopy to standard high-definition endoscopy in 1,000 adults aged 40 and older who are scheduled for a routine upper endoscopy. The goal is to see if the AI tool helps doctors find more gastric neoplasms (abnormal growths) that might otherwise be missed. Participants will undergo two examinations in a row, and the number of growths found in each will be compared.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-assisted upper gastrointestinal endoscopy device
What this could lead to: If successful, this could show that AI helps doctors spot more early stomach growths during routine endoscopy, potentially leading to earlier detection.
What could go wrong: This is a single-center study with 1,000 participants, and AI may not work equally well in all settings or populations. The AI tool is an aid, not a replacement for the doctor's judgment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTIFICIAL INTELLIGENCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARTIFICIAL INTELLIGENCE GASTRIC NEOPLASM

Contacts and locations

Locations

Queen Mary Hospital, the University of Hong Kong
RECRUITING

Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.